FIELD: medicine. SUBSTANCE: for treatment of different autoimmune diseases (multiple sclerosis, rheumatic arthritis, etc.) trophoblastic beta-1-glycoprotein (TBG) is proposed as a medicinal agent. TBG does not show any allergic reactions, it induces SUPPRESSOR activity of lymphocytes in patients with autoimmune diseases and used as immunocorrecting preparation. Optimal doses of TBG are 3-120 mcg which is administrated by parenterally or intravenously routes. EFFECT: enhanced effectiveness of agent. 5 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING IMMUNOREGULATORY PROPERTY AND ITS USING IN TREATMENT OF AUTOIMMUNE DISEASES | 2006 |
|
RU2303995C1 |
| AGENT FOR TREATING AUTOIMMUNE DISEASES | 2013 |
|
RU2528337C1 |
| DRUG PREPARATION POSSESSING IMMUNOREGULATORY PROPERTY FOR TREATING IMMUNE DISEASES | 2012 |
|
RU2504401C2 |
| PEPTIDE WITH IMMUNOREGULATING PROPERTY AND COMPOSITION BASED ON THEREOF | 2002 |
|
RU2210382C1 |
| PEPTIDE COMPOSITION ELICITING IMMUNITY REGULATING PROPERTY | 2003 |
|
RU2244719C1 |
| PEPTIDE COMPOSITION POSSESSING IMMUNOREGULATORY PROPERTY | 2004 |
|
RU2266297C1 |
| METHOD OF THERAPY OF REMITTENT MULTIPLE SCLEROSIS | 2012 |
|
RU2523058C2 |
| METHOD OF AUTOIMMUNE DISEASES TREATMENT | 1991 |
|
RU2005513C1 |
| METHOD FOR PRODUCTION OF POLYCLONAL T-CELL VACCINE USEFUL IN TREATMENT OF IMMUNOLOGICAL DISORDERS | 2004 |
|
RU2277422C2 |
| METHOD FOR TREATING THE PATIENTS SUFFERING FROM AUTOIMMUNE DISEASES | 1999 |
|
RU2159635C2 |
